drugset
drugset / Trial / NCT00175851

Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy

NCT00175851 ↗

Phase 3 Withdrawn UCB Pharma
Non-randomizedSingle-groupOpen-label

Summary

This is a safety and efficacy study of add-on therapy with seletracetam in epilepsy patients who have participated in a previous seletracetam study

Timeline

Start
2008-05
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Seletracetam Small molecule — —

Indications

epilepsy